Superdisintegrants Market Size, Share & Trends Analysis Report By Product (Croscarmellose Sodium, Crospovidone), By Form (Tablets and Capsules, Mouth-dissolving Films), By Region, And Segment Forecasts, 2024 - 2030

Superdisintegrants Market Size, Share & Trends Analysis Report By Product (Croscarmellose Sodium, Crospovidone), By Form (Tablets and Capsules, Mouth-dissolving Films), By Region, And Segment Forecasts, 2024 - 2030

Superdisintegrants Market Growth & Trends

The global superdisintegrants market size is expected to reach USD 769.8 million by 2030, registering to grow at a CAGR of 5.3% from 2024 to 2030 according to a new report by Grand View Research, Inc. Superdisintegrants help in the disintegration of tablet or capsule content into small particles and create a greater surface area for speedy drug release.

A number of fast disintegrating tablets such as salbutamol sulphate, and cetirizine hydrochloride in tablet/capsule dosage form for respiratory disorders (bronchitis, asthma, and coughing) are formulated for pediatric and geriatric patients, due to their difficulty or discomfort in swallowing. Superdisintegrant such as crospovidone, croscarmellose sodium, and sodium starch glycolate are used in optimized concentration to formulate such tablets/capsules along with different binders such as MCC and PVP K-30.

Superdisintegrants Market Report Highlights

• The market study suggests that crospovidone dominated the overall market in 2023. Crospovidone is completely insoluble in water and rapidly disperses and swells in water. It has the greatest rate of swelling and surface area to volume ratio compared to other disintegrants.
• Tablets and capsules commanded a dominant market share of 62.3% in 2023, primarily driven by the extensive use of crospovidone as an excipient. Crospovidone's advantageous properties, including inhibition of recrystallization and enhancement of dissolution and disintegration of solid dosage forms, translate to improved swallowability for both geriatric and pediatric patients..
• The mouth-dissolving film segment is expected to grow at the highest growth rate during the forecast period. It is the preferred choice for patients as compared to tablets and capsules due to the greater flexibility and comfort of the former.
• North America dominated the regional segment with the largest revenue share in 2023, due to number of superdisintegrants manufacturers operating in the region and prolific research and development initiatives
• Some of the major companies operating in this market are BASF SE; Ashland; DuPont.; Roquette Frères.; DFE Pharma; JRS PHARMA; Asahi Kasei Corporation.; Merck KGaA; Corel Pharma Chem and others.

Please note The report will be delivered in 2-3 business days upon order notification.